Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin.

× No keyword cloud information.

52 in total

1. Individualized drug dosing using RBF-Galerkin method: Case of anemia management in chronic kidney disease.

Authors: Hossein Mirinejad; Adam E Gaweda; Michael E Brier; Jacek M Zurada; Tamer Inanc
Journal: Comput Methods Programs Biomed Date: 2017-06-23 Impact factor: 5.428

Review 2. Chronic renal disease.

Authors: Malvinder S Parmar
Journal: BMJ Date: 2002-07-13

3. Recombinant erythropoietin therapy in renal and nonrenal anemia.

Authors: A J Erslev
Journal: West J Med Date: 1992-08

4. Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis.

Authors: F Fabris; I Cordiano; M L Randi; A Casonato; G Montini; G Zacchello; A Girolami
Journal: Pediatr Nephrol Date: 1991-03 Impact factor: 3.714

5. Plasma erythropoietin level and iron reserves in haemodialysis patients with and without acquired cystic kidney disease.

Authors: M Majdan; A Ksiazek; M Kozioł; D Spasiewicz
Journal: Int Urol Nephrol Date: 1997 Impact factor: 2.370

Review 6. The potential of biotechnology to improve the quality of life of patients with renal failure.

Authors: W E Bloembergen; A Laupacis
Journal: Drug Saf Date: 1991 Jan-Feb Impact factor: 5.606

Review 7. Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors: Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal: Clin Pharmacokinet Date: 2013-12 Impact factor: 6.447

8. Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts.

Authors: Oluwatoyin Fatai Bamgbola; Fredrick J Kaskel; Maria Coco
Journal: Pediatr Nephrol Date: 2008-09-18 Impact factor: 3.714

9. Effect of recombinant human erythropoietin on synthesis of methylguanidine in uraemic patients on haemodialysis or continuous ambulatory peritoneal dialysis.

Authors: I Sasagawa; T Nakada; Y Kubota; T Sawamura; H Suzuki; T Hashimoto
Journal: Int Urol Nephrol Date: 1994 Impact factor: 2.370

10. Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.

Authors: M E Stevens; G P Summerfield; A A Hall; C A Beck; A J Harding; J R Cove-Smith; A D Paterson
Journal: BMJ Date: 1992-02-22